Travel distance and stereotactic body radiotherapy for localized prostate cancer

CONCLUSIONSDefinitive prostate SBRT use increased more than 3‐fold since 2004, with a significant increase in use coinciding with early reports of short‐term efficacy. Long‐distance travel for treatment was associated with greater than twice the odds of receipt of definitive prostate SBRT compared with short‐distance travel, suggesting that treatment decisions with unknown long‐term clinical implications may be strongly driven by sociodemographic factors. Cancer 2017. © 2017 American Cancer Society.

Source: Cancer - December 12, 2017 Category: Cancer & Oncology Authors: Brandon A. Mahal, Yu ‐Wei Chen, Roshan V. Sethi, Oscar A. Padilla, David D. Yang, Janice Chavez, Vinayak Muralidhar, Jim C. Hu, Felix Y. Feng, Karen E. Hoffman, Neil E. Martin, Daniel E. Spratt, James B. Yu, Peter F. Orio, Paul L. Nguyen Tags: Original Article Source Type: research